RxNews Recap for 05-04-11 Print E-mail
By BioMedReports.com Staff   
Wednesday, 04 May 2011 18:53
Below is a look at some of the headlines for companies that made news in the healthcare sector on May 04, 2011.

Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare diseases, today announced financial results for the first quarter ended March 31, 2011.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) today announced it will report first quarter 2011 financial results after the NASDAQ Global Select Market closes on Tuesday, May 10, 2011.

Auxilium Pharmaceuticals, Inc. (Nasdaq:AUXL) today announced that executive management will participate in the Bank of America Merrill Lynch 2011 Health Care Conference during May 10-12, 2011 at the Encore at Wynn Las Vegas.

Bacterin International Holdings, Inc. (NYSE Amex:BONE), a developer of revolutionary bone graft material, today announced that its chairman and CEO, Guy Cook, will present at SEVEN; Noble Financial Capital Markets' Seventh Annual Equity Conference at the Hard Rock Hotel in Hollywood, Florida, on Monday, May 16, 2011 at 4:00p.m. Eastern Time.

CNS Response, Inc. (OTCBB: CNSO) today announced that CEO George Carpenter will be presenting at SEVEN; Noble Financial Capital Markets' Seventh Annual Equity Conference.

Codexis, Inc. (Nasdaq:CDXS) today announced the company will participate in the Barclays Capital Clean Solutions Conference, to be held in New York, NY on May 18-19, 2011.

Cytori Therapeutics (NASDAQ: CYTX) will install a comprehensive StemSource® Cell Bank in Hong Kong for Neo Derm (HK) Ltd.

D. Medical Industries Ltd. (NASDAQ:DMED)(TASE:DMED); ("D. Medical" or the "Company"), a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery, announced today that its subsidiary, Spring-Set Health Solutions Ltd. ("Spring-Set"), has completed a usability and safety study (the "Study") of its Spring Universal Infusion Set product which is designed for subcutaneous delivery of medicine, including insulin, from an external infusion pump.

Given Imaging Ltd. (NASDAQ: GIVN) today announced financial results for the first quarter ended March 31, 2011.

Hansen Medical, Inc. (NASDAQ: HNSN)
, a global leader in flexible medical robotics and the developer of robotic technology for accurate 3D control of catheter movement, today reported recent business highlights and financial results for the first quarter ended March 31, 2011.

Inovio Pharmaceuticals, Inc. (NYSE Amex:INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the company will make presentations at two scientific conferences:  15th Annual Conference on Women's Health Care IssuesHosted by International Infectious Disease Society for Obstetrics and Gynecology-USAWeill Greenberg CenterNew York, NY  10021.

InterMune, Inc. (NASDAQ:ITMN) today announced that Dan Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the Bank of America Merrill Lynch 2011 Health Care Conference in Las Vegas, NV on May 11, 2011, at 1:00 p.m. PDT.  

InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), and The University of Miami Miller School of Medicine's Miami Project to Cure Paralysis, the world's most comprehensive spinal cord injury research center, today announced a strategic research collaboration for the development of novel SCI treatments.

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease ("Keryx" or the "Company"), today announced the pricing of an underwritten registered offering of 7,021,277 shares of its common stock at a price of $4.70 per share.

MedLink International, Inc. (OTCQB: MLKNA) today announced that it has retained KCSA Strategic Communications, a leading New York-based communications firm, to direct the Company's investor relations program.

MMRGlobal, Inc. (OTCBB: MMRF)
, provider of secure and easy-to-use Personal Health Records (www.mmrvideos.com) and electronic safe deposit box storage solutions for consumers (www.myesafevideos.com) and electronic document management systems for healthcare professionals (www.mmrprovideos.com), today announced that for the first quarter ended March 31, 2011, revenues are projected to be more than 600 percent of those reported in the first quarter of 2010.

NxStage Medical, Inc. (Nasdaq:NXTM), a leading manufacturer of innovative dialysis products, today reported financial results for the first quarter of 2011 ended March  31, 2011, with total revenue above the top end of its guidance range.

Oracle (NASDAQ: ORCL)--News Facts-Supporting health sciences organizations' commitment to ensuring the safety and effectiveness of their products, Oracle today announced the availability of Oracle® Argus Safety 7.0, a market-leading integrated global adverse events (AE) management and regulatory reporting solution.

Oncothyreon Inc. (NASDAQ:ONTY) today announced that it has closed an underwritten public offering of 11,500,000 shares of its common stock at a price to the public of $4.00 per share for gross proceeds of $46.0 million.

Pacira Pharmaceuticals, Inc. (Nasdaq:PCRX), an emerging specialty pharmaceutical company, today announced that financial results for the company's first quarter ended March 31, 2011 will be released before the market opens on Wednesday, May 11, 2011.

Pharmacyclics, Inc. (Nasdaq:PCYC) today reported recent developments and financial results for its fiscal third quarter that ended March 31, 2011.

Tengion, Inc. (Nasdaq:TNGN), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Thursday, May 12, 2011 at 8:30 a.m. EDT to provide a business update and discuss its first quarter 2011 financial results.  

Transgenomic, Inc. (OTCBB: TBIO) announced a significant enhancement to its FAMILION Brugada Syndrome (BrS) test panel at the 2011 Heart Rhythm Society meeting in San Francisco.

Trinity Biotech plc (NASDAQ:TRIB)
, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that is has obtained CE Marking (European regulatory approval) for the Premier Hb9210 (Premier).

VentriPoint Diagnostics Ltd. ("VentriPoint") (TSX VENTURE:VPT)(PINK SHEETS:VPTDF) announces that its just filed Management's Discussion and Analysis (MD&A) provides a review of its financial and operational activities during 2010 through April 29, 2011, and presents its current status and elements of its planned operational focus during the remainder of 2011.

David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced the Company has identified 45 published manuscripts detailing independent studies involving the use of its PD2i® nonlinear algorithm to identify a wide variety of medical disorders and conditions.

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus